Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis

Published:2007-05-09 Issue:7 Volume:46 Page:1148-1152
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Walsh C. A. E.,Minnock P.,Slattery C.,Kennedy N.,Pang F.,Veale D. J.,Bresnihan B.,FitzGerald O.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design;Advanced Drug Delivery Reviews;2024-06

2. Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions;Expert Opinion on Drug Delivery;2023-06-03

3. Understanding patient preferences for handheld autoinjectors versus wearable large-volume injectors;Expert Opinion on Drug Delivery;2022-12-26

4. Formative and Validation Human Factors studies of a new disposable autoinjector for subcutaneous delivery of chronic disease therapies;Expert Opinion on Drug Delivery;2021-08-27

5. Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom;Applied Health Economics and Health Policy;2021-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP